Filed: 2/13/2024ACC: 0001104659-24-015432
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 60 equity positions with a total reported market value of $1.79B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
60
Positions
$1.79B
Total AUM (reported)
87.31M
Total Shares
Allocation by class
COM$1.48B83.0%
SPONSORED ADR$200.44M11.2%
CL A$53.32M3.0%
SHS$31.26M1.7%
SPONSORED ADS$7.13M0.4%
CLASS A ORD$6.87M0.4%
COM CL A$3.79M0.2%
Portfolio Concentration
Top 3$684.68M38.3%
4–10$481.95M27.0%
11–25$421.86M23.6%
Rest$198.62M11.1%
Top 3 weight
38.3%
Top 10 weight
65.3%
Voting Authority Distribution
Total shares with voting rights: 87.31M
Sole
Full voting authority
87.31M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole60
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings60
Rows:
Karuna Therapeutics Inc
SOLEShares1.38M
TypeSH
Market value$437.15M
24.46%
Sole
1.38M
Shared
0.00
None
0.00
RayzeBio Inc
SOLEShares2.42M
TypeSH
Market value$150.42M
8.42%
Sole
2.42M
Shared
0.00
None
0.00
Natera Inc
SOLEShares1.55M
TypeSH
Market value$97.11M
5.43%
Sole
1.55M
Shared
0.00
None
0.00
Ascendis Pharma A/S
SOLEShares754.03K
TypeSH
Market value$94.97M
5.31%
Sole
754.03K
Shared
0.00
None
0.00
Merck & Co Inc
SOLEShares857.97K
TypeSH
Market value$93.54M
5.23%
Sole
857.97K
Shared
0.00
None
0.00
Aerovate Therapeutics Inc
SOLEShares3.76M
TypeSH
Market value$85.06M
4.76%
Sole
3.76M
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares850.58K
TypeSH
Market value$57.29M
3.21%
Sole
850.58K
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares3.47M
TypeSH
Market value$53.32M
2.98%
Sole
3.47M
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares1.46M
TypeSH
Market value$51.91M
2.90%
Sole
1.46M
Shared
0.00
None
0.00
ImmunoGen Inc
SOLEShares1.55M
TypeSH
Market value$45.87M
2.57%
Sole
1.55M
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares126.96K
TypeSH
Market value$42.83M
2.40%
Sole
126.96K
Shared
0.00
None
0.00
Eli Lilly & Co
SOLEShares64.53K
TypeSH
Market value$37.61M
2.10%
Sole
64.53K
Shared
0.00
None
0.00
Cytokinetics Inc
SOLEShares414.21K
TypeSH
Market value$34.58M
1.94%
Sole
414.21K
Shared
0.00
None
0.00
Celldex Therapeutics Inc
SOLEShares844.01K
TypeSH
Market value$33.47M
1.87%
Sole
844.01K
Shared
0.00
None
0.00
CymaBay Therapeutics Inc
SOLEShares1.41M
TypeSH
Market value$33.35M
1.87%
Sole
1.41M
Shared
0.00
None
0.00
Immatics NV
SOLEShares2.97M
TypeSH
Market value$31.26M
1.75%
Sole
2.97M
Shared
0.00
None
0.00
Sanofi
SOLEShares598.98K
TypeSH
Market value$29.79M
1.67%
Sole
598.98K
Shared
0.00
None
0.00
Inhibrx Inc
SOLEShares772.96K
TypeSH
Market value$29.37M
1.64%
Sole
772.96K
Shared
0.00
None
0.00
Kenvue Inc
SOLEShares1.21M
TypeSH
Market value$25.99M
1.45%
Sole
1.21M
Shared
0.00
None
0.00
Kura Oncology Inc
SOLEShares1.67M
TypeSH
Market value$23.98M
1.34%
Sole
1.67M
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares1.08M
TypeSH
Market value$23.25M
1.30%
Sole
1.08M
Shared
0.00
None
0.00
Marinus Pharmaceuticals Inc
SOLEShares1.87M
TypeSH
Market value$20.36M
1.14%
Sole
1.87M
Shared
0.00
None
0.00
Stryker Corporation
SOLEShares62.79K
TypeSH
Market value$18.80M
1.05%
Sole
62.79K
Shared
0.00
None
0.00
Incyte Corp
SOLEShares296.57K
TypeSH
Market value$18.62M
1.04%
Sole
296.57K
Shared
0.00
None
0.00
Geron Corp
SOLEShares8.81M
TypeSH
Market value$18.60M
1.04%
Sole
8.81M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Karuna Therapeutics IncSOLE | COM | 1.38M | SH | $437.15M 24.46% | 1.38M | 0.00 | 0.00 |
RayzeBio IncSOLE | COM | 2.42M | SH | $150.42M 8.42% | 2.42M | 0.00 | 0.00 |
Natera IncSOLE | COM | 1.55M | SH | $97.11M 5.43% | 1.55M | 0.00 | 0.00 |
Ascendis Pharma A/SSOLE | SPONSORED ADR | 754.03K | SH | $94.97M 5.31% | 754.03K | 0.00 | 0.00 |
Merck & Co IncSOLE | COM | 857.97K | SH | $93.54M 5.23% | 857.97K | 0.00 | 0.00 |
Aerovate Therapeutics IncSOLE | COM | 3.76M | SH | $85.06M 4.76% | 3.76M | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 850.58K | SH | $57.29M 3.21% | 850.58K | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 3.47M | SH | $53.32M 2.98% | 3.47M | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 1.46M | SH | $51.91M 2.90% | 1.46M | 0.00 | 0.00 |
ImmunoGen IncSOLE | COM | 1.55M | SH | $45.87M 2.57% | 1.55M | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM | 126.96K | SH | $42.83M 2.40% | 126.96K | 0.00 | 0.00 |
Eli Lilly & CoSOLE | COM | 64.53K | SH | $37.61M 2.10% | 64.53K | 0.00 | 0.00 |
Cytokinetics IncSOLE | COM | 414.21K | SH | $34.58M 1.94% | 414.21K | 0.00 | 0.00 |
Celldex Therapeutics IncSOLE | COM | 844.01K | SH | $33.47M 1.87% | 844.01K | 0.00 | 0.00 |
CymaBay Therapeutics IncSOLE | COM | 1.41M | SH | $33.35M 1.87% | 1.41M | 0.00 | 0.00 |
Immatics NVSOLE | SHS | 2.97M | SH | $31.26M 1.75% | 2.97M | 0.00 | 0.00 |
SanofiSOLE | SPONSORED ADR | 598.98K | SH | $29.79M 1.67% | 598.98K | 0.00 | 0.00 |
Inhibrx IncSOLE | COM | 772.96K | SH | $29.37M 1.64% | 772.96K | 0.00 | 0.00 |
Kenvue IncSOLE | COM | 1.21M | SH | $25.99M 1.45% | 1.21M | 0.00 | 0.00 |
Kura Oncology IncSOLE | COM | 1.67M | SH | $23.98M 1.34% | 1.67M | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 1.08M | SH | $23.25M 1.30% | 1.08M | 0.00 | 0.00 |
Marinus Pharmaceuticals IncSOLE | COM | 1.87M | SH | $20.36M 1.14% | 1.87M | 0.00 | 0.00 |
Stryker CorporationSOLE | COM | 62.79K | SH | $18.80M 1.05% | 62.79K | 0.00 | 0.00 |
Incyte CorpSOLE | COM | 296.57K | SH | $18.62M 1.04% | 296.57K | 0.00 | 0.00 |
Geron CorpSOLE | COM | 8.81M | SH | $18.60M 1.04% | 8.81M | 0.00 | 0.00 |
Page 1 of 3